663194-10-3 Usage
Uses
Used in Pharmaceutical Industry:
4-(4-BROMOPYRIMIDIN-2-YL)MORPHOLINE is used as a chemical intermediate for the synthesis of various drugs and active pharmaceutical ingredients, contributing to the development of new medications with diverse therapeutic properties.
Used in Agrochemicals:
In the agrochemical industry, 4-(4-BROMOPYRIMIDIN-2-YL)MORPHOLINE may have potential applications, possibly serving as a precursor for the development of new agrochemicals with improved efficacy and selectivity.
Used in Material Science:
4-(4-BROMOPYRIMIDIN-2-YL)MORPHOLINE also holds potential in material science, where it could be employed in the creation of novel materials with specific properties, such as enhanced stability or reactivity, for various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 663194-10-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,3,1,9 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 663194-10:
(8*6)+(7*6)+(6*3)+(5*1)+(4*9)+(3*4)+(2*1)+(1*0)=163
163 % 10 = 3
So 663194-10-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10BrN3O/c9-7-1-2-10-8(11-7)12-3-5-13-6-4-12/h1-2H,3-6H2
663194-10-3Relevant academic research and scientific papers
Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation
Woodring, Jennifer L.,Bachovchin, Kelly A.,Brady, Kimberly G.,Gallerstein, Mitchell F.,Erath, Jessey,Tanghe, Scott,Leed, Susan E.,Rodriguez, Ana,Mensa-Wilmot, Kojo,Sciotti, Richard J.,Pollastri, Michael P.
, p. 446 - 459 (2017/10/24)
Human African trypanosomiasis (HAT) is a deadly disease in need of new chemotherapeutics that can cross into the central nervous system. We previously reported the discovery of 2 (NEU-617), a small molecule with activity against T. brucei bloodstream prol
1,4-DISUBSTITUTED ISOQUINILONE DERIVATIVES AS RAF-KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
-
Page/Page column 50-51, (2010/02/11)
This invention relates to compounds of formula (I) wherein the variable substituents are described herein. The compounds are useful for the treatment of conditions and diseases characterized by an aberrant MAP kinase signaling pathway, such as cancer.
